Next Generation Sequencing (NGS) Market: Global Opportunity Analysis and Industry Forecast, 2019–2026

The global next generation sequencing market size was valued at $4,533 million in 2018, and is estimated to reach $18,565 million by 2026, growing at a CAGR of 19.2% from 2019 to 2026. Next-generation sequencing (NGS) is a novel procedure for sequencing genomes at low costs and high speed with improved efficiency. NGS also is known as deep sequencing and parallel sequencing is a technology that has revolutionized molecular biology and genomics research. It is a high throughput, non-Sanger based sequencing method.

Next generation sequencing has made sequencing of genomes very rapid and cost-effective. Through this method, billions of DNA strands can be sequenced efficiently. Next generation sequencing has made it possible to conveniently sequence whole genomes, and analyze various DNA-protein interactions. This technique allows the researcher to focus, study, and interpret deep sequence target regions. Next generation sequencing can be utilized through varied interventions such as oncology, biomarker studies, drug discovery, understanding reproductive health, and personalized genomics.

 

Technological advancements in sequencing platforms, surge in applications of next generation sequencing, and an increase in genome mapping programs drive the growth of the global next generation sequencing market. In addition, the rise in awareness pertaining to next generation sequencing and an increase in investment in research, development, and innovation supplement the market growth. However, lack of skilled professionals, ethical & legal limitations related to next generation sequencing, and standardization concerns in sequencing procedures impede the market growth. Furthermore, the use of cloud computing as a potential data management service and untapped emerging economies offer lucrative opportunities for the market players.

 

The next generation sequencing market is segmented based on product, application, technology, end-user, and region. Based on the product, the market is divided into consumables, platforms, and services. The consumables product segment is further bifurcated as sample preparation consumables and other consumables. The sample preparation consumables are further segmented into DNA fragmentation, end-repair, A-Tailing & size selection, library preparation & target enrichment, and quality control. The platform NGS product segment is classified into HiSeq, MiSeq, Ion Torrent, SOLiD, Pacbio Rs II & Sequel System, and other sequencing platforms.

 

The services segment is divided into sequencing services and data management services. The sequencing services are further divided into RNA Sequencing, Whole Exome Sequencing, Whole Genome Sequencing, Targeted Sequencing, Chip Sequencing, De Novo Sequencing, and Methyl Sequencing. The data management services further divided into NGS data analysis services, NGS data analysis software & workbenches, and NGS storage, management & cloud computing solutions.

 

Based on application, the market is divided into diagnostics, biomarkers and cancer, reproductive health, personalized medicine, agriculture and animal research, other applications. By Technology, the market is segmented into sequencing by synthesis, ion semiconductor sequencing, sequencing by ligation, pyrosequencing, single-molecule real-time sequencing, and other technologies. Depends on end-user, the market is categorized into academic & clinical research centers, pharmaceutical & biotechnology companies, hospitals & clinics, and other end-user. Based on the region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

 

Based on the region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America accounted for the largest market share in the next-generation sequencing market in 2015 and is expected to retain its dominance throughout the forecast period. This is primarily attributed to higher buying power, availability, and applications that favor the utilization of NGS in this region. There is also an increase in agreements and collaborations between different market players and health centers to promote and utilize NGS in this region. However, Asia-Pacific is expected to emerge as a lucrative area with maximum growth potential, owing to the improvement in R&D facilities, available disposable income, and rapidly developing economic conditions.

 

Product development is a key strategy adopted by market players. The report provides a comprehensive analysis of the key players that operate in the global next-generation sequencing market.

NEXT GENERATION SEQUENCING MARKET ON THE BASIS OF PRODUCT

• Consumables
• Sample Preparation Consumables
• DNA Fragmentation, End Repair, A-Tailing, and Size Selection
• Library Preparation & Target Enrichment
• Quality Control
• Other Consumables
• Platforms
• HiSeq
• MiSeq
• Ion Torrent
• SOLiD
• Pacbio Rs II and Sequel System
• Other Sequencing Platforms
• Services
• Sequencing Services
• RNA Sequencing
• Whole Exome Sequencing
• Whole Genome Sequencing
• Targeted Sequencing
• Chip Sequencing
• De Novo Sequencing
• Methyl Sequencing
• Data Management Services
• NGS Data Analysis Services
• NGS Data Analysis Software & Workbenches
• ment and Cloud Computing SolutionsNGS Storage, Manage

NEXT GENERATION SEQUENCING MARKET ON THE BASIS OF BY APPLICATION

• Diagnostics
• Biomarkers and Cancer
• Reproductive Health
• Personalized Medicine
• Agriculture and Animal Research
• Other Applications

NEXT GENERATION SEQUENCING MARKET ON THE BASIS OF TECHNOLOGY

• Sequencing by Synthesis
• Ion Semiconductor Sequencing
• Sequencing by Ligation
• Pyrosequencing
• Single-Molecule Real-Time Sequencing
• Other Technologies

NEXT GENERATION SEQUENCING MARKET ON THE BASIS OF END USER

• Academic and Clinical Research Centers
• Pharmaceutical and Biotechnology Companies
• Hospitals and Clinics
• Other End User

• Illumina, Inc.
• Thermo Fisher Scientific, Inc.
• Pacific Biosciences of California, Inc.
• Beijing Genomics Institute
• Qiagen N.V.
• 454 Life Sciences Corporation (Roche Holding AG)
• Agilent Technologies, Inc.
• Perkinelmer, Inc.
• Genomatix GmbH
• PierianDx

Other players in the value chain include (profiles not included in the report)

• Eurofins Scientific
• Gatc Biotech AG
• Macrogen, Inc.
• Oxford Nanopore Technologies, Ltd.
• Bio-Rad Laboratories, Inc.
• DNASTAR, Inc.
• Biomatters Ltd.
• Partek Inc.
• New England Biolabs, Inc.
• Myriad Genetics, Inc.

TABLE OF CONTENT:

 

TABLE 01. GLOBAL NEXT GENERATION SEQUENCING MARKET, BY PRODUCT, 2018-2026 ($MILLION)

TABLE 02. NEXT GENERATION SEQUENCING MARKET REVENUE FOR CONSUMABLES, BY TYPE 2018–2026 ($MILLION)

TABLE 03. EAR BIONICS MARKET REVENUE, BY TYPE, 2018–2026 ($MILLION)

TABLE 04. DNA FRAGMENTATION, END REPAIR, A-TAILING & SIZE SELECTION: KEY PRODUCTS

TABLE 05. LIBRARY PREPARATION & TARGET ENRICHMENT: KEY PRODUCTS

TABLE 06. NEXT GENERATION SEQUENCING MARKET REVENUE FOR CONSUMABLES, BY REGION 2018–2026($MILLION)

TABLE 07. NEXT GENERATION SEQUENCING MARKET REVENUE FOR PLATFORMS, BY TYPE 2018–2026($MILLION)

TABLE 08. NEXT GENERATION SEQUENCING MARKET REVENUE FOR PLATFORM, BY REGION 2018–2026($MILLION)

TABLE 09. NEXT GENERATION SEQUENCING MARKET REVENUE FOR SERVICES, BY TYPE 2018–2026 ($MILLION)

TABLE 10. SEQUENCING SERVICES MARKET REVENUE, BY TYPE, 2018–2026 ($MILLION)

TABLE 11. SEQUENCING SERVICES MARKET REVENUE, BY TYPE, 2018–2026 ($MILLION)

TABLE 12. NGS DATA ANALYSIS SOFTWARE & WORKBENCHES: KEY PRODUCTS

TABLE 13. NEXT GENERATION SEQUENCING MARKET REVENUE FOR SERVICES, BY REGION 2018–2026($MILLION)

TABLE 14. GLOBAL NEXT GENERATION SEQUENCING MARKET REVENUE, BY APPLICATION, 2018-2026 ($MILLION)

TABLE 15. NEXT GENERATION SEQUENCING MARKET REVENUE OF NEXT GENERATION SEQUENCING FOR BIOMARKERS AND CANCER, BY REGION 2018–2026($MILLION)

TABLE 16. NEXT GENERATION SEQUENCING MARKET REVENUE OF NEXT GENERATION SEQUENCING FOR DIAGNOSTICS, BY REGION 2018–2026($MILLION)

TABLE 17. NEXT GENERATION SEQUENCING MARKET REVENUE OF NEXT GENERATION SEQUENCING FOR REPRODUCTIVE HEALTH, BY REGION 2018–2026($MILLION)

TABLE 18. NEXT GENERATION SEQUENCING MARKET REVENUE OF NEXT GENERATION SEQUENCING FOR PERSONALIZED MEDICINE, BY REGION 2018–2026($MILLION)

TABLE 19. NEXT GENERATION SEQUENCING MARKET REVENUE OF NEXT GENERATION SEQUENCING FOR AGRICULTURE AND ANIMAL RESEARCH, BY REGION 2018–2026($MILLION)

TABLE 20. NEXT GENERATION SEQUENCING MARKET REVENUE OF NEXT GENERATION SEQUENCING FOR OTHER APPLICATIONS, BY REGION 2018–2026($MILLION)

TABLE 21. GLOBAL NEXT GENERATION SEQUENCING MARKET REVENUE, BY TECHNOLOGY, 2018-2026 ($MILLION)

TABLE 22. NEXT GENERATION SEQUENCING MARKET REVENUE OF NEXT GENERATION SEQUENCING FOR SEQUENCING BY SYNTHESIS, BY REGION 2018–2026($MILLION)

TABLE 23. NEXT GENERATION SEQUENCING MARKET REVENUE OF NEXT GENERATION SEQUENCING FOR ION SEMICONDUCTOR SEQUENCING, BY REGION 2018–2026($MILLION)

TABLE 24. NEXT GENERATION SEQUENCING MARKET REVENUE OF NEXT GENERATION SEQUENCING FOR SEQUENCING BY LIGATION, BY REGION 2018–2026($MILLION)

TABLE 25. NEXT GENERATION SEQUENCING MARKET REVENUE OF NEXT GENERATION SEQUENCING FOR PYROSEQUENCING, BY REGION 2018–2026($MILLION)

TABLE 26. NEXT GENERATION SEQUENCING MARKET REVENUE OF NEXT GENERATION SEQUENCING FOR SINGLE-MOLECULE-REAL-TIME SEQUENCING, BY REGION 2018–2026($MILLION)

TABLE 27. NEXT GENERATION SEQUENCING MARKET REVENUE OF NEXT GENERATION SEQUENCING FOR OTHER TECHNOLOGIES, BY REGION 2018–2026($MILLION)

TABLE 28. GLOBAL NEXT GENERATION SEQUENCING MARKET REVENUE, BY END USER, 2018–2026 ($MILLION)

TABLE 29. NEXT GENERATION SEQUENCING MARKET REVENUE FOR ACADEMIC AND CLINICAL RESEARCH CENTERS, BY REGION 2018–2026($MILLION)

TABLE 30. NEXT GENERATION SEQUENCING MARKET REVENUE FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2018–2026($MILLION)

TABLE 31. NEXT GENERATION SEQUENCING MARKET REVENUE FOR HOSPITALS AND CLINICS, BY REGION, 2018–2026($MILLION)

TABLE 32. NEXT GENERATION SEQUENCING MARKET REVENUE FOR OTHER END USERS, BY REGION, 2018–2026($MILLION)

TABLE 33. NEXT GENERATION SEQUENCING MARKET REVENUE, BY REGION, 2018–2026 ($MILLION)

TABLE 34. NORTH AMERICA NEXT GENERATION SEQUENCING MARKET, BY COUNTRY, 2018–2026 ($MILLION)

TABLE 35. U.S. NEXT GENERATION SEQUENCING MARKET, BY PRODUCT, 2018–2026 ($MILLION)

TABLE 36. U.S. NEXT GENERATION SEQUENCING MARKET, BY APPLICATION, 2018–2026 ($MILLION)

TABLE 37. U.S. NEXT GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2018–2026 ($MILLION)

TABLE 38. U.S. NEXT GENERATION SEQUENCING MARKET, BY END USER, 2018–2026 ($MILLION)

TABLE 39. CANADA NEXT GENERATION SEQUENCING MARKET, BY PRODUCT, 2018–2026 ($MILLION)

TABLE 40. CANADA NEXT GENERATION SEQUENCING MARKET, BY APPLICATION, 2018–2026 ($MILLION)

TABLE 41. CANADA NEXT GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2018–2026 ($MILLION)

TABLE 42. CANADA NEXT GENERATION SEQUENCING MARKET, BY END USER, 2018–2026 ($MILLION)

TABLE 43. MEXICO NEXT GENERATION SEQUENCING MARKET, BY PRODUCT, 2018–2026 ($MILLION)

TABLE 44. MEXICO NEXT GENERATION SEQUENCING MARKET, BY APPLICATION, 2018–2026 ($MILLION)

TABLE 45. MEXICO NEXT GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2018–2026 ($MILLION)

TABLE 46. MEXICO NEXT GENERATION SEQUENCING MARKET, BY END USER, 2018–2026 ($MILLION)

TABLE 47. NORTH AMERICA NEXT GENERATION SEQUENCING MARKET, BY PRODUCT, 2018–2026 ($MILLION)

TABLE 48. NORTH AMERICA NEXT GENERATION SEQUENCING MARKET, BY APPLICATION, 2018–2026 ($MILLION)

TABLE 49. NORTH AMERICA NEXT GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2018–2026 ($MILLION)

TABLE 50. NORTH AMERICA NEXT GENERATION SEQUENCING MARKET, BY END USER, 2018–2026 ($MILLION)

TABLE 51. EUROPE NEXT GENERATION SEQUENCING MARKET, BY COUNTRY, 2018–2026 ($MILLION)

TABLE 52. GERMANY NEXT GENERATION SEQUENCING MARKET, BY PRODUCT, 2018–2026 ($MILLION)

TABLE 53. GERMANY NEXT GENERATION SEQUENCING MARKET, BY APPLICATION, 2018–2026 ($MILLION)

TABLE 54. GERMANY NEXT GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2018–2026 ($MILLION)

TABLE 55. GERMANY NEXT GENERATION SEQUENCING MARKET, BY END USER, 2018–2026 ($MILLION)

TABLE 56. FRANCE NEXT GENERATION SEQUENCING MARKET, BY PRODUCT, 2018–2026 ($MILLION)

TABLE 57. FRANCE NEXT GENERATION SEQUENCING MARKET, BY APPLICATION, 2018–2026 ($MILLION)

TABLE 58. FRANCE NEXT GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2018–2026 ($MILLION)

TABLE 59. FRANCE NEXT GENERATION SEQUENCING MARKET, BY END USER, 2018–2026 ($MILLION)

TABLE 60. ITALY NEXT GENERATION SEQUENCING MARKET, BY PRODUCT, 2018–2026 ($MILLION)

TABLE 61. ITALY NEXT GENERATION SEQUENCING MARKET, BY APPLICATION, 2018–2026 ($MILLION)

TABLE 62. ITALY NEXT GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2018–2026 ($MILLION)

TABLE 63. ITALY NEXT GENERATION SEQUENCING MARKET, BY END USER, 2018–2026 ($MILLION)

TABLE 64. UK NEXT GENERATION SEQUENCING MARKET, BY PRODUCT, 2018–2026 ($MILLION)

TABLE 65. UK NEXT GENERATION SEQUENCING MARKET, BY APPLICATION, 2018–2026 ($MILLION)

TABLE 66. UK NEXT GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2018–2026 ($MILLION)

TABLE 67. UK NEXT GENERATION SEQUENCING MARKET, BY END USER, 2018–2026 ($MILLION)

TABLE 68. REST OF EUROPE NEXT GENERATION SEQUENCING MARKET, BY PRODUCT, 2018–2026 ($MILLION)

TABLE 69. REST OF EUROPE NEXT GENERATION SEQUENCING MARKET, BY APPLICATION, 2018–2026 ($MILLION)

TABLE 70. REST OF EUROPE NEXT GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2018–2026 ($MILLION)

TABLE 71. REST OF EUROPE NEXT GENERATION SEQUENCING MARKET, BY END USER, 2018–2026 ($MILLION)

TABLE 72. EUROPE NEXT GENERATION SEQUENCING MARKET, BY PRODUCT, 2018–2026 ($MILLION)

TABLE 73. EUROPE NEXT GENERATION SEQUENCING MARKET, BY APPLICATION, 2018–2026 ($MILLION)

TABLE 74. EUROPE NEXT GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2018–2026 ($MILLION)

TABLE 75. EUROPE NEXT GENERATION SEQUENCING MARKET, BY END USER, 2018–2026 ($MILLION)

TABLE 76. ASIA-PACIFIC NEXT GENERATION SEQUENCING MARKET, BY COUNTRY, 2018–2026 ($MILLION)

TABLE 77. AUSTRALIA NEXT GENERATION SEQUENCING MARKET, BY PRODUCT, 2018–2026 ($MILLION)

TABLE 78. AUSTRALIA NEXT GENERATION SEQUENCING MARKET, BY APPLICATION, 2018–2026 ($MILLION)

TABLE 79. AUSTRALIA NEXT GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2018–2026 ($MILLION)

TABLE 80. AUSTRALIA NEXT GENERATION SEQUENCING MARKET, BY END USER, 2018–2026 ($MILLION)

TABLE 81. JAPAN NEXT GENERATION SEQUENCING MARKET, BY PRODUCT, 2018–2026 ($MILLION)

TABLE 82. JAPAN NEXT GENERATION SEQUENCING MARKET, BY APPLICATION, 2018–2026 ($MILLION)

TABLE 83. JAPAN NEXT GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2018–2026 ($MILLION)

TABLE 84. JAPAN NEXT GENERATION SEQUENCING MARKET, BY END USER, 2018–2026 ($MILLION)

TABLE 85. INDIA NEXT GENERATION SEQUENCING MARKET, BY PRODUCT, 2018–2026 ($MILLION)

TABLE 86. INDIA NEXT GENERATION SEQUENCING MARKET, BY APPLICATION, 2018–2026 ($MILLION)

TABLE 87. INDIA NEXT GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2018–2026 ($MILLION)

TABLE 88. INDIA NEXT GENERATION SEQUENCING MARKET, BY END USER, 2018–2026 ($MILLION)

TABLE 89. CHINA NEXT GENERATION SEQUENCING MARKET, BY PRODUCT, 2018–2026 ($MILLION)

TABLE 90. CHINA NEXT GENERATION SEQUENCING MARKET, BY APPLICATION, 2018–2026 ($MILLION)

TABLE 91. CHINA NEXT GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2018–2026 ($MILLION)

TABLE 92. CHINA NEXT GENERATION SEQUENCING MARKET, BY END USER, 2018–2026 ($MILLION)

TABLE 93. SOUTH KOREA NEXT GENERATION SEQUENCING MARKET, BY PRODUCT, 2018–2026 ($MILLION)

TABLE 94. SOUTH KOREA NEXT GENERATION SEQUENCING MARKET, BY APPLICATION, 2018–2026 ($MILLION)

TABLE 95. SOUTH KOREA NEXT GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2018–2026 ($MILLION)

TABLE 96. SOUTH KOREA NEXT GENERATION SEQUENCING MARKET, BY END USER, 2018–2026 ($MILLION)

TABLE 97. TAIWAN NEXT GENERATION SEQUENCING MARKET, BY PRODUCT, 2018–2026 ($MILLION)

TABLE 98. TAIWAN NEXT GENERATION SEQUENCING MARKET, BY APPLICATION, 2018–2026 ($MILLION)

TABLE 99. TAIWAN NEXT GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2018–2026 ($MILLION)

TABLE 100. TAIWAN NEXT GENERATION SEQUENCING MARKET, BY END USER, 2018–2026 ($MILLION)

TABLE 101. REST OF ASIA-PACIFIC NEXT GENERATION SEQUENCING MARKET, BY PRODUCT, 2018–2026 ($MILLION)

TABLE 102. REST OF ASIA-PACIFIC NEXT GENERATION SEQUENCING MARKET, BY APPLICATION, 2018–2026 ($MILLION)

TABLE 103. REST OF ASIA-PACIFIC NEXT GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2018–2026 ($MILLION)

TABLE 104. REST OF ASIA-PACIFIC NEXT GENERATION SEQUENCING MARKET, BY END USER, 2018–2026 ($MILLION)

TABLE 105. ASIA-PACIFIC NEXT GENERATION SEQUENCING MARKET, BY PRODUCT, 2018–2026 ($MILLION)

TABLE 106. ASIA-PACIFIC NEXT GENERATION SEQUENCING MARKET, BY APPLICATION, 2018–2026 ($MILLION)

TABLE 107. ASIA-PACIFIC NEXT GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2018–2026 ($MILLION)

TABLE 108. ASIA-PACIFIC NEXT GENERATION SEQUENCING MARKET, BY END USER, 2018–2026 ($MILLION)

TABLE 109. LAMEA NEXT GENERATION SEQUENCING MARKET, BY COUNTRY, 2018–2026 ($MILLION)

TABLE 110. BRAZIL NEXT GENERATION SEQUENCING MARKET, BY PRODUCT, 2018–2026 ($MILLION)

TABLE 111. BRAZIL NEXT GENERATION SEQUENCING MARKET, BY APPLICATION, 2018–2026 ($MILLION)

TABLE 112. BRAZIL NEXT GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2018–2026 ($MILLION)

TABLE 113. BRAZIL NEXT GENERATION SEQUENCING MARKET, BY END USER, 2018–2026 ($MILLION)

TABLE 114. SAUDI ARABIA NEXT GENERATION SEQUENCING MARKET, BY PRODUCT, 2018–2026 ($MILLION)

TABLE 115. SAUDI ARABIA NEXT GENERATION SEQUENCING MARKET, BY APPLICATION, 2018–2026 ($MILLION)

TABLE 116. SAUDI ARABIA NEXT GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2018–2026 ($MILLION)

TABLE 117. SAUDI ARABIA NEXT GENERATION SEQUENCING MARKET, BY END USER, 2018–2026 ($MILLION)

TABLE 118. SOUTH AFRICA NEXT GENERATION SEQUENCING MARKET, BY PRODUCT, 2018–2026 ($MILLION)

TABLE 119. SOUTH AFRICA NEXT GENERATION SEQUENCING MARKET, BY APPLICATION, 2018–2026 ($MILLION)

TABLE 120. SOUTH AFRICA NEXT GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2018–2026 ($MILLION)

TABLE 121. SOUTH AFRICA NEXT GENERATION SEQUENCING MARKET, BY END USER, 2018–2026 ($MILLION)

TABLE 122. REST OF LAMEA NEXT GENERATION SEQUENCING MARKET, BY PRODUCT, 2018–2026 ($MILLION)

TABLE 123. REST OF LAMEA NEXT GENERATION SEQUENCING MARKET, BY APPLICATION, 2018–2026 ($MILLION)

TABLE 124. REST OF LAMEA NEXT GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2018–2026 ($MILLION)

TABLE 125. REST OF LAMEA NEXT GENERATION SEQUENCING MARKET, BY END USER, 2018–2026 ($MILLION)

TABLE 126. LAMEA NEXT GENERATION SEQUENCING MARKET, BY PRODUCT, 2018–2026 ($MILLION)

TABLE 127. LAMEA NEXT GENERATION SEQUENCING MARKET, BY APPLICATION, 2018–2026 ($MILLION)

TABLE 128. LAMEA NEXT GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2018–2026 ($MILLION)

TABLE 129. LAMEA NEXT GENERATION SEQUENCING MARKET, BY END USER, 2018–2026 ($MILLION)

TABLE 130. AGILENT: COMPANY SNAPSHOT

TABLE 131. AGILENT: OPERATING SEGMENTS

TABLE 132. AGILENT: PRODUCT PORTFOLIO

TABLE 133. BGI: COMPANY SNAPSHOT

TABLE 134. BGI: OPERATING SEGMENTS

TABLE 135. BGI: PRODUCT PORTFOLIO

TABLE 136. ROCHE: COMPANY SNAPSHOT

TABLE 137. ROCHE: OPERATING SEGMENTS

TABLE 138. ROCHE: PRODUCT PORTFOLIO

TABLE 139. ILLUMINA: COMPANY SNAPSHOT

TABLE 140. ILLUMINA: OPERATING SEGMENTS

TABLE 141. ILLUMINA: PRODUCT PORTFOLIO

TABLE 142. INTREXON: COMPANY SNAPSHOT

TABLE 143. INTREXON: OPERATING SEGMENTS

TABLE 144. INTREXON: PRODUCT PORTFOLIO

TABLE 145. PACBIO: COMPANY SNAPSHOT

TABLE 146. PACBIO: OPERATING SEGMENTS

TABLE 147. PACBIO: PRODUCT PORTFOLIO

TABLE 148. PERKINELMER: COMPANY SNAPSHOT

TABLE 149. PERKINELMER: OPERATING SEGMENTS

TABLE 150. PERKINELMER: PRODUCT PORTFOLIO

TABLE 151. PIERIANDX: COMPANY SNAPSHOT

TABLE 152. PIERIANDX: OPERATING SEGMENTS

TABLE 153. PIERIANDX: PRODUCT PORTFOLIO

TABLE 154. QIAGEN: COMPANY SNAPSHOT

TABLE 155. QIAGEN: OPERATING SEGMENTS

TABLE 156. QIAGEN: PRODUCT PORTFOLIO

TABLE 157. THERMO FISHER: COMPANY SNAPSHOT

TABLE 158. THERMO FISHER: OPERATING SEGMENTS

TABLE 159. THERMO FISHER: PRODUCT PORTFOLIO LIST OF FIGURES

 

FIGURE 01. KEY MARKET SEGMENTS

FIGURE 02. EXECUTIVE SUMMARY

FIGURE 03. TOP IMPACTING FACTORS

FIGURE 04. TOP INVESTMENT POCKETS

FIGURE 05. MARKET EVOLUTION

FIGURE 06. VALUE CHAIN ANALYSIS

FIGURE 07. PATENTS ANALYSIS BY YEAR, 2016 THROUGH 2018

FIGURE 08. PATENT ANALYSIS, BY COUNTRY

FIGURE 09. PATENT ANALYSIS, BY APPLICANT

FIGURE 10. NGS MARKET: PRODUCT & SERVICES SEGMENATION

FIGURE 11. DNA FRAGMENTATION, END REPAIR, A-TAILING AND SIZE SELECTION MARKET, 2018–2026 ($MILLION)

FIGURE 12. LIBRARY PREPARATION & TARGET ENRICHMENT MARKET, 2018–2026 ($MILLION)

FIGURE 13. QUALITY CONTROL MARKET, 2018–2026 ($MILLION)

FIGURE 14. OTHER CONSUMABLES MARKET, 2018–2026 ($MILLION)

FIGURE 15. COMPARATIVE SHARE ANALYSIS OF NEXT GENERATION SEQUENCING MARKET FOR CONSUMABLES, BY COUNTRY, 2018 & 2026 (%)

FIGURE 16. HISEQ SERIES PLATFORM MARKET, 2018–2026 ($MILLION)

FIGURE 17. MISEQ SERIES PLATFORM MARKET, 2018–2026 ($MILLION)

FIGURE 18. ION TORRENT PLATFORM MARKET, 2018–2026 ($MILLION)

FIGURE 19. SOLID PLATFORM MARKET, 2018–2026 ($MILLION)

FIGURE 20. PACBIO RS II AND SEQUEL SYSTEM MARKET, 2018–2026 ($MILLION)

FIGURE 21. OTHER SEQUENCING PLATFORMS MARKET, 2018–2026 ($MILLION)

FIGURE 22. COMPARATIVE SHARE ANALYSIS OF NEXT GENERATION SEQUENCING MARKET FOR PLATFORM, BY COUNTRY, 2018 & 2026 (%)

FIGURE 23. RNA SEQUENCING MARKET, 2018–2026 ($MILLION)

FIGURE 24. WHOLE EXOME SEQUENCING MARKET, 2018–2026 ($MILLION)

FIGURE 25. WHOLE GENOME SEQUENCING MARKET, 2018–2026 ($MILLION)

FIGURE 26. TARGETED SEQUENCING MARKET, 2018–2026 ($MILLION)

FIGURE 27. CHIP SEQUENCING MARKET, 2018–2026 ($MILLION)

FIGURE 28. DE NOVO SEQUENCING MARKET, 2018–2026 ($MILLION)

FIGURE 29. METHYL SEQUENCING MARKET, 2018–2026 ($MILLION)

FIGURE 30. NGS DATA ANALYSIS SERVICES MARKET, 2018–2026 ($MILLION)

FIGURE 31. NGS ANALYSIS SOFTWARE & WORKBENCHES MARKET, 2018–2026 ($MILLION)

FIGURE 32. NGS STORAGE, MANAGEMENT, AND CLOUD COMPUTING SOLUTIONS MARKET, 2018–2026 ($MILLION)

FIGURE 33. COMPARATIVE SHARE ANALYSIS OF NEXT GENERATION SEQUENCING MARKET FOR SERVICES, BY COUNTRY, 2018 & 2026 (%)

FIGURE 34. COMPARATIVE SHARE ANALYSIS OF NEXT GENERATION SEQUENCING FOR BIOMARKERS AND CANCER, BY COUNTRY, 2018 & 2026 (%)

FIGURE 35. COMPARATIVE SHARE ANALYSIS OF NEXT GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY COUNTRY, 2018 & 2026 (%)

FIGURE 36. COMPARATIVE SHARE ANALYSIS OF NEXT GENERATION SEQUENCING MARKET FOR REPRODUCTIVE HEALTH, BY COUNTRY, 2018 & 2026 (%)

FIGURE 37. COMPARATIVE SHARE ANALYSIS OF NEXT GENERATION SEQUENCING MARKET FOR PERSONALIZED MEDICINE, BY COUNTRY, 2018 & 2026 (%)

FIGURE 38. COMPARATIVE SHARE ANALYSIS OF NEXT GENERATION SEQUENCING MARKET FOR AGRICULTURE AND ANIMAL RESEARCH, BY COUNTRY, 2018 & 2026 (%)

FIGURE 39. COMPARATIVE SHARE ANALYSIS OF NEXT GENERATION SEQUENCING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2018 & 2026 (%)

FIGURE 40. COMPARATIVE SHARE ANALYSIS OF NEXT GENERATION SEQUENCING FOR SEQUENCING BY SYNTHESIS, BY COUNTRY, 2018 & 2026 (%)

FIGURE 41. COMPARATIVE SHARE ANALYSIS OF NEXT GENERATION SEQUENCING MARKET FOR ION SEMICONDUCTOR SEQUENCING, BY COUNTRY, 2018 & 2026 (%)

FIGURE 42. COMPARATIVE SHARE ANALYSIS OF NEXT GENERATION SEQUENCING MARKET FOR SEQUENCING BY LIGATION, BY COUNTRY, 2018 & 2026 (%)

FIGURE 43. COMPARATIVE SHARE ANALYSIS OF NEXT GENERATION SEQUENCING MARKET FOR PYROSEQUENCING, BY COUNTRY, 2018 & 2026 (%)

FIGURE 44. COMPARATIVE SHARE ANALYSIS OF NEXT GENERATION SEQUENCING MARKET FOR SINGLE-MOLECULE-REAL-TIME SEQUENCING, BY COUNTRY, 2018 & 2026 (%)

FIGURE 45. COMPARATIVE SHARE ANALYSIS OF NEXT GENERATION SEQUENCING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2018 & 2026 (%)

FIGURE 46. COMPARATIVE SHARE ANALYSIS OF NEXT GENERATION SEQUENCING MARKET FOR ACADEMIC AND CLINICAL RESEARCH CENTERS, BY COUNTRY, 2018 & 2026 (%)

FIGURE 47. COMPARATIVE SHARE ANALYSIS OF NEXT GENERATION SEQUENCING MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018 & 2026 (%)

FIGURE 48. COMPARATIVE SHARE ANALYSIS OF NEXT GENERATION SEQUENCING MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2018 & 2026 (%)

FIGURE 49. COMPARATIVE SHARE ANALYSIS OF NEXT GENERATION SEQUENCING MARKET FOR OTHER END USERS, BY COUNTRY, 2018 & 2026 (%)

FIGURE 50. MARKET SHARE ANALYSIS: NEXT GENERATION SEQUENCING MARKET, 2018 (%)

FIGURE 51. PRODUCT MAPPING OF TOP 10 PLAYERS

FIGURE 52. AGILENT: NET SALES, 2016–2018 ($MILLION)

FIGURE 53. AGILENT: REVENUE SHARE BY SEGMENT, 2018 (%)

FIGURE 54. AGILENT: REVENUE SHARE BY REGION, 2018 (%)

FIGURE 55. ROCHE: NET SALES, 2016–2018 ($MILLION)

FIGURE 56. ROCHE: REVENUE SHARE BY SEGMENT, 2018 (%)

FIGURE 57. ROCHE: REVENUE SHARE BY SEGMENT, 2018 (%)

FIGURE 58. ILLUMINA: NET SALES, 2016–2018 ($MILLION)

FIGURE 59. FIGURE 5. ILLUMINA: REVENUE SHARE BY SEGMENT, 2018 (%)

FIGURE 60. ILLUMINA: REVENUE SHARE BY REGION, 2018 (%)

FIGURE 61. INTREXON: NET SALES, 2016–2018 ($MILLION)

FIGURE 62. PACBIO: NET SALES, 2016–2018 ($MILLION)

FIGURE 63. PACBIO: REVENUE SHARE BY REGION, 2018 (%)

FIGURE 64. PERKINELMER: NET SALES, 2016–2018 ($MILLION)

FIGURE 65. PERKINELMER: REVENUE SHARE BY SEGMENT, 2018 (%)

FIGURE 66. PERKINELMER: REVENUE SHARE BY REGION, 2018 (%)

FIGURE 67. QIAGEN: NET SALES, 2016–2018 ($MILLION)

FIGURE 68. QIAGEN: REVENUE SHARE BY SEGMENT, 2018 (%)

FIGURE 69. QIAGEN: REVENUE SHARE BY REGION, 2018 (%)

FIGURE 70. THERMO FISHER: NET SALES, 2016–2018 ($MILLION)

FIGURE 71. THERMO FISHER: REVENUE SHARE BY SEGMENT, 2018 (%)

FIGURE 72. THERMO FISHER: REVENUE SHARE BY REGION, 2018 (%